Average Co-Inventor Count = 4.36
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Esbatech, an Alcon Biomedical Research Unit LLC (7 from 36 patents)
2. Novartis Ag (5 from 3,923 patents)
3. University Of Zürich (2 from 97 patents)
4. Delenex Therapeutics Ag (2 from 5 patents)
5. Esbatech, an Alcon Boimedical Research Unit, LLC (1 from 1 patent)
6. Esbatech - a Novartis Company LLC (1 patent)
15 patents:
1. 12331104 - Hepatitis B antibodies
2. 11932681 - Hepatitis B antibodies
3. 10647780 - Reversal binding agents for anti-factor XI/XIa antibodies and uses thereof
4. 10570190 - Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
5. 10465011 - Factor XI antibodies and methods of use
6. 10125186 - Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
7. 9683034 - Stable and soluble antibodies inhibiting TNFα
8. 9518108 - Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
9. 9315572 - Stable and soluble antibodies inhibiting TNF alpha
10. 9273126 - Humanized antibodies against the beta-amyloid peptide
11. 8853362 - Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
12. 8691228 - Stable and soluble antibodies inhibiting TNFα
13. 8389693 - Stable and soluble antibodies inhibiting TNFα
14. 8323647 - Humanized antibodies against the β-amyloid peptide
15. 8067547 - Stable and soluble antibodies inhibiting TNFα